![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 401/04 | |
C07D 401/14 | |||
C07D 403/10 | |||
C07D 405/14 | |||
C07D 409/14 | |||
C07D 413/14 | |||
C07D 417/10 | |||
C07D 417/14 | |||
A61K 31/4439 | |||
A61K 31/444 | |||
A61K 31/496 | |||
A61K 31/5377 | |||
A61P 31/00 |
(11) | Patento numeris | 2861576 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 13730655.1 |
Europos patento paraiškos padavimo data | 2013-05-09 | |
(97) | Europos patento paraiškos paskelbimo data | 2015-04-22 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2018-01-10 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/IB2013/053771 |
Data | 2013-05-09 |
(87) | Numeris | WO 2013/171642 |
Data | 2013-11-21 |
(30) | Numeris | Data | Šalis |
201261647174 P | 2012-05-15 | US | |
201361789842 P | 2013-03-15 | US |
(72) |
FURET, Pascal, CH
GROTZFELD, Robert Martin, CH
JONES, Darryl Brynley, CH
MANLEY, Paul, CH
MARZINZIK, Andreas, CH
PELLE, Xavier Francois Andre, CH
SALEM, Bahaa, CH
SCHOEPFER, Joseph, CH
JAHNKE, Wolfgang, CH
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1 |
BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1 |